Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers. - Wikidata - wikimedia - TriplyDB

Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers.

Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers.

http://www.wikidata.org/entity/Q36954741

about

Identification of differential proteins in nasopharyngeal carcinoma cells with p53 silence by proteome analysis A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma An unconventional antigen translated by a novel internal ribosome entry site elicits antitumor humoral immune reactions Germ cell-specific heat shock protein 105 binds to p53 in a temperature-sensitive manner in rat testis The physical association of multiple molecular chaperone proteins with mutant p53 is altered by geldanamycin, an hsp90-binding agent Heat shock protein 70B' (HSP70B') expression and release in response to human oxidized low density lipoprotein immune complexes in macrophages Autoimmunity to the M(r) 32,000 subunit of replication protein A in breast cancer De-novo humoral immune responses to cancer-associated autoantigens during transition from chronic liver disease to hepatocellular carcinoma.Detection of serum anti-p53 antibodies from patients with ovarian cancer in China: correlation to clinical parameters.Detection and monitoring of serum p53 antibodies in patients with colorectal cancer.Autoantibodies to tumor-associated antigens in epithelial ovarian carcinoma.p53 autoantibodies as potential detection and prognostic biomarkers in serous ovarian cancer.Characterization of the immunostimulatory properties of Leishmania infantum HSP70 by fusion to the Escherichia coli maltose-binding protein in normal and nu/nu BALB/c mice.Chaperones in cell cycle regulation and mitogenic signal transduction: a review.Autoantibodies to tumor-associated antigens in breast carcinoma.Expressions of HSP70 and HSP27 in hepatocellular carcinoma Inhibition of the erbB-2 tyrosine kinase receptor in breast cancer cells by phosphoromonothioate and phosphorodithioate antisense oligonucleotides.Biomarkers of gene expression: growth factors and oncoproteins.A mouse mutant p53 product recognized by CD4+ and CD8+ T cells.Nuclear p53 protein accumulates preferentially in medullary and high-grade ductal but rarely in lobular breast carcinomas Comparison between p53 staining in tissue sections and p53 proteins levels measured by an ELISA technique Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein.Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis p53 mutations and overexpression in locally advanced breast cancers The relationship between serum p53 autoantibodies and characteristics of human breast cancer.Detection of the anti-p53 antibody response in malignant and benign pancreatic disease.Absence of p53 autoantibodies in a significant proportion of breast cancer patients.Measurement and evaluation of serum anti-p53 antibody levels in patients with lung cancer at its initial presentation: a prospective study Do heat shock proteins have a role in breast cancer?Increased serum p53 antibody levels indicate poor prognosis in patients with colorectal cancer Initiation of autoimmunity to the p53 tumor suppressor protein by complexes of p53 and SV40 large T antigen.Autoimmunity and apoptosis Cytoplasmic sequestration of wild-type p53 protein impairs the G1 checkpoint after DNA damage Use of autoantibodies in breast cancer screening and diagnosis.Serum anti-p53 antibodies in gastric adenocarcinoma patients are associated with poor prognosis, lymph node metastasis and poorly differentiated nuclear grade.Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma.Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: a population-based epidemiological study.Serum p53 autoantibodies in patients with minimal lesions of ductal carcinoma in situ of the breast Serum p53 antibodies: predictors of survival in small-cell lung cancer?The clinical significance of autoantibodies in gastrointestinal malignancies: an overview.

P2860

Q24337782-128178AC-5CBD-421F-9DED-A3A22B0A6C34 Q24676730-CAF9198E-7A1C-4438-8C19-8FDCAFB194B9 Q28264336-6CDB2614-3984-4957-975D-5E4D9E4E749F Q28580918-30CB3122-EAA4-4FED-B91B-C8A8A9D3C869 Q28584270-8FBA4E78-8CDD-4FDA-9AC2-2F3EFF0FDEBD Q30494525-D3F97EE9-49A1-4389-ACFD-5137A7C7FE55 Q31042618-38293F84-825A-471F-8E6C-6C397F72E0A3 Q31938591-A17875DE-D145-4C57-BDFE-1D59DD7D55D8 Q33303413-CBFF6952-14A9-4313-BC21-F4E30930B78B Q33617886-C08F84F6-4AF4-4586-99E4-07F7523A070A Q33633387-6A5FB5AE-E07D-4B85-BC3F-EAE39FB47609 Q33725961-F57D65F9-2EC3-40E1-893F-1573BCEF7775 Q33749003-46128F9C-FF27-41B6-AE00-4178901B0D33 Q34095732-501C467A-55EA-4113-A287-4B38E9E8E464 Q34339160-B661EE0E-3F1D-488F-8F63-823349AFEFDC Q34561718-B65A6D49-DD97-4C4C-A9C3-CED0402FC7B2 Q34618574-559D0AC0-FF0C-4298-BBC2-2F2F86B3BCEE Q34638885-802992D4-82A5-4880-AAE1-BD8B2AAAE940 Q35159385-B66F6A97-7DF1-4C5D-AFCF-45FC5233EDED Q35832474-BE8B9DE7-9D8C-4600-9503-B541110499D0 Q35977071-299528A5-A6AD-49B3-AFF8-B98948B188A1 Q35978507-9A264737-3C4C-4B0A-B06C-E3D53B010823 Q35979121-3F114610-F8DE-45B6-9923-CA26E43EE963 Q35979192-2CD81AE1-28BB-4237-9E71-A52915C0EF5E Q35979208-B8B3A588-506C-47AE-A1CF-4D2835ABFD74 Q36080258-F292B40F-AC65-4DFB-88EB-108B041673E2 Q36081057-ACF92225-3A9F-4DB6-8CA9-1E0844E352DF Q36115287-E28B5138-EABD-446A-AFD8-4BDE7CADF198 Q36136058-B257704C-DD78-4DAF-8317-EB741E03D6D1 Q36292740-9D5A320F-7B32-487B-A7E6-3BD63C82EB20 Q36362919-064176C4-42A6-43B6-B744-7EB58E45CFEE Q36362953-789CB26E-CA05-41CC-9740-5F535B6072CA Q36557538-EF3B4A6B-D0BC-4BE7-998E-26CD644E070C Q36573831-F5522E11-D9D4-4277-A8AA-40D6A069FAAF Q36617828-63C71F59-E655-4B2D-B493-FC0572A065D8 Q36618179-9E755F53-2CA7-4CDC-A1E4-D41EBC977616 Q36618943-81DF1BC0-14FF-4C1A-993E-108848C29A50 Q36619714-1147E201-4317-46E9-B6AC-2DBC046B68F2 Q36621503-99A24524-4B53-44DC-9CDD-AEE8EEBD11E7 Q36764924-0C188569-95D3-4EC9-987D-48E46FF7F3B1

P2860

Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers.

http://www.wikidata.org/entity/Q36954741

description

1992 nî lūn-bûn

@nan

1992年の論文

@ja

1992年論文

@yue

1992年論文

@zh-hant

1992年論文

@zh-hk

1992年論文

@zh-mo

1992年論文

@zh-tw

1992年论文

@wuu

1992年论文

@zh

1992年论文

@zh-cn

name

Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers.

@en

type

label

Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers.

@en

prefLabel

Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers.

@en

P1433

Q36954741-D7564A50-4352-4759-8E70-656D45B9264F

P1476

Q36954741-FC9292C8-8025-4262-83EF-67124BDB7774

P2093

Q36954741-318E1CF9-7B69-4316-AED1-D7E056031287

Q36954741-6F6BDDE5-D079-4356-AB2C-262842221979

Q36954741-FCE1C583-ABA3-42FE-B56A-0CC65B16DE05

P2860

Q36954741-05EE4823-432B-485E-AA15-30AA83D0AE1B

Q36954741-15BA144A-FE34-4510-A470-FFE42349037C

Q36954741-18B9D887-CD75-414A-B547-74764E85360F

Q36954741-1EC61341-FB12-4C6C-A678-6BA2ADA504B6

Q36954741-22264381-ECBA-4FA9-B256-D673353697FE

Q36954741-3541E47F-54F1-4366-ABCE-F82FD25297A2

Q36954741-39DD04D8-784A-42A4-9210-248487CB60A6

Q36954741-3B5C5AE1-5F44-4994-8BC1-BF4173528398

Q36954741-439D7B7A-AF1C-423F-8ED7-33B68A1C7BAF

Q36954741-48698978-DB2D-4A41-A15C-252D2EFBC848

P304

Q36954741-D34B2F56-E7A5-4E90-A307-E9C6F74A6F40

P31

Q36954741-DB330201-7FC3-4A67-994E-0000124DA93C

P356

Q36954741-BA0DFEAF-49BD-4305-A6B6-776F5BB20320

P407

Q36954741-082F76B9-D3A9-4FE9-AAF4-095BE2063D45

P433

Q36954741-F03B9BA3-0ACA-4198-AD2F-62E1D8869323

P478

Q36954741-31CA133C-C019-4998-82E2-44D8DA485707

P577

Q36954741-8E3CD8B4-001C-4BDE-8D7A-E13EDE3CBD25

P5875

Q36954741-90A39B2D-32CF-4DB3-8729-813DBF89067B

P698

Q36954741-03797874-5084-4EC5-9AF5-B1996F9DE57B

P932

Q36954741-043CA791-9915-4BEA-93B5-127BAD979068

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers.

@en

P2093

A M Davidoff

http://www.w3.org/2001/XMLSchema#string

J D Iglehart

http://www.w3.org/2001/XMLSchema#string

J R Marks

http://www.w3.org/2001/XMLSchema#string

P2860

Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene

Mutations in the p53 gene occur in diverse human tumour types

p53 mutations in human cancers

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

p53 mutations in colorectal cancer

Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types.

A subfamily of stress proteins facilitates translocation of secretory and mitochondrial precursor polypeptides.

Precise epitope mapping of the murine transformation-associated protein, p53.

Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation.

Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life

P304

3439-3442

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.89.8.3439

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

89

http://www.w3.org/2001/XMLSchema#string

P577

1992-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

21781212

http://www.w3.org/2001/XMLSchema#string

P698

1373500

http://www.w3.org/2001/XMLSchema#string

P932

48883

http://www.w3.org/2001/XMLSchema#string